Ajuste direto para aquisição de RISPERIDONA [100 MG/0.490 ML; PÓ SUSP INJ LP; SERINGA] e RISPERIDONA [75 MG/0.383 ML; PÓ SUSP INJ LP; SERINGA]

ID 13647658 · Portal BASE
Price
Base Price
€597,008 .00
Effective Price
€2,638 .00 -99.6%
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Lisboa, Amadora
Bidder Count
—
Winner
LAB. FARMACEUTICOS ROVI, SA.
NIF 980166705
Company
Dates
Publication
25 Feb 2026
Celebration
25 Feb 2026
Contracting Entity
HOSPITAL PROFESSOR DOUTOR FERNANDO FONSECA, EPE
NIF 503035416
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 10 · LOW RISK
A9 · Abnormal Price Reduction
A9_PRICE_REDUCTION
LOW
Base price
597008.0
Total effective price
2638.0
Ratio
0.0044
Direction
reduction
Rule
A9 price reduction: ratio 0.0044 outside [0.5, 1.5]
Detected 2026-03-06